Buy Oncozac®
/assets/images/Banner_2_mobile@1x.jpg

Reignite Passion in Life

Alleviate side effects of serious illness treatments with a new generation of adjuvant therapy11

Reignite Passion in Life

Extracted with patented processing technologies11

World's first and only USP-verified Yunzhi ingredient*

Research and developed with CUHK

* As of November 2021
/assets/images/Homebanner_02_mobile.png

Moments Worth
Fighting For

Alleviate side effects of serious illness treatments with a new generation of adjuvant therapy11

Reignite Passion in Life

Extracted with patented processing technologies11

World's first and only USP-verified Yunzhi ingredient*

Research and developed with CUHK

* As of November 2021
/assets/images/Homebanner_03_mobile.png

Where Compassion
And Healing Come Together

Alleviate side effects of serious illness treatments with a new generation of adjuvant therapy11

Reignite Passion in Life

Extracted with patented processing technologies11

World's first and only USP-verified Yunzhi ingredient*

Research and developed with CUHK

* As of November 2021
Benefit Benefit Benefit Immunity Immunity Immunity Product Product Product Certification Certification Certification Research Research Research Manufacturing Manufacturing Manufacturing Administration Administration Administration Services Services Resources

Live life the way you're meant to — Promoting a better Quality of Life with Oncozac®

Co-developed with the School of Pharmacy at the Chinese University of Hong Kong and containing the United States Pharmacopeia-verified ingredient ONCO-Z®, Oncozac® is proven to relieve treatment-induced side effects (such as nausea and fatigue) to promote a better quality of life25, 29, and ultimately increase survival rates for serious illness patients7, 17, 21,24, 26.

/assets/images/product_oncozac_1.png

Co-developed with the School of Pharmacy at the Chinese University of Hong Kong and containing the United States Pharmacopeia-verified ingredient ONCO-Z®, Oncozac® is proven to relieve treatment-induced side effects (such as nausea and fatigue) to promote a better quality of life25, 29, and ultimately increase survival rates for serious illness patients7, 17, 21,24, 26.

Spotlight & Recognition

Reduction in side effects from treatment

Reduction in side effects from treatment

Oncozac® is effective in helping to alleviate the side effects caused by serious illness treatments, therefore helping to promote a better quality of life

Common side effects which Oncozac® is proven to alleviate include, but are not limited to, oral ulcers, nausea, vomiting, loss of appetite, severe weight loss, fatigue, night sweats, anxiety, heart palpitations, insomnia, shortness of breath, susceptibility to infection etc.25, 29.

More Details

Reduction in side effects from treatment

Positive results from decades of clinical studies show that extracts from Yunzhi mushrooms (which include Polysaccharides K "PSK" and Polysaccharopeptides "PSP") are effective in improving the Quality of Life for patients by alleviating symptoms associated with serious illness treatments.

If you would like to learn more, please refer to the supporting studies page on a variety of reserach conducted on the use of Yunzhi extracts in combating serious illnesses.

Back

Increase survival rates with enhanced immunity

Increase in survival rates with enhanced immunity

Numerous clinical studies have been conducted on the effects of Yunzhi extracts on survival rates of various serious illness patients with overwhelmingly positive results. With an optimal level of active ingredients from Yunzhi extracts, Oncozac® can play a powerful role in increasing survival rates of patients7, 17, 21,24, 26.

Oncozac® is also effective in enhancing immune cells such as: T-lymphocytes, B-lymphocytes, monocytes, macrophages, bone marrow cells, natural killer cells and lymphokine-activated cells 2, 3, 13, 23 to strengthen the body’s ability to fight abnormal cells and other infections3,23.

More Details

Increase in survival rates with enhanced immunity

Whilst survival rates differ based on the serious illness type, the overall trend for Yunzhi-based adjuvant therapies is overwhelmingly positive. For example, it has been scientifically proven that for Breast-related serious illnesses, a specific group of Stage IIA T2N1 and ER negative patients had a 5-year overall survival rate of 95.7% when Yunzhi extracts were combined with chemotherapy, as opposed to 80.8% for a group with chemotherapy alone16.

Furthermore, the body's immune system is critical in maintaining the longevity of ones' health. Oncozac® is scientifically proven to significantly enhance the body’s immunity3,13, therefore reducing the chances of infection3,23 through the increase of antibodies and a variety of cytokines such as: interleukin-2, interleukin-6, interferon and TNF3,23.

Back

Pre-treatment preparation

Pre-treatment preparation

Some patients may be advised by medical professionals that they are not able to undergo treatment due to their body's weak immune system or lack of White Blood Cells. Oncozac® is effective in stimulating and proliferating immune cells (such as White Blood Cells, Bone Marrow Cells and Macrophages)2,3,13, therefore enhancing patients' immune systems7,12 and allowing some patients to undergo treatments.

More Details

Pre-treatment preparation

While serious illness treatments such as chemotherapy, radiotherapy, or surgery are designed to eliminate abnormal cells, these treatments also take a toll on our healthy cells as well, impairing our immune system during the process. Stimulating the growth of immune cells not only ensures patients can resume their treatments, but it also reduces the chance of infection during treatment3, 23.

Back

Post-treatment maintenance

Post-treatment maintenance

One of the major complications of treatments is the damage caused to a patients' immune system, which may prevent patients from continuing their treatment. Oncozac® is effective in activating the immune system and restoring immune cells to healthy levels3,13, therefore allowing some patients with weakened immune systems to resume their treatments.

More Details

Post-treatment maintenance

While serious illness treatments such as chemotherapy, radiotherapy, or surgery are designed to eliminate abnormal cells, these treatments also take a toll on our healthy cells as well, impairing our immune system during the process. Stimulating the growth of immune cells not only ensures patients can resume their treatments, but it also reduces the chance of infection during treatment3, 23.

Back

Reduction in the chance of recurrence

Reduction in the chance of recurrence

Oncozac® helps to suppress the spread and growth of abnormal cells7,11,14,15,18,27, helping to reduce the chance of recurrence which may make serious illnesses more manageable for patients.

More Details

Reduction in the chance of recurrence

Evidence-based research has revealed that Yunzhi extracts have tumoricidal effects in addition to enhancing the immune system. In clinical studies it was found that tumor sizes in animals were reduced1, 15 with the addition of Yunzhi extracts. Furthermore, when assessing liver and breast tumors specifically, the growth of abnormal cells in the liver and breast were suppressed28 as well; the growth of abnormal cells from the stomach, lung, bone marrow, blood-forming tissues, and lymph node were also markedly inhibited20.

Back

Reduction in side effects from treatment

01.Reduction in side effects from treatment

Oncozac® is effective in helping to alleviate the side effects caused by serious illness treatments, therefore helping to promote a better quality of life

Common side effects which Oncozac® is proven to alleviate include, but are not limited to, oral ulcers, nausea, vomiting, loss of appetite, severe weight loss, fatigue, night sweats, anxiety, heart palpitations, insomnia, shortness of breath, susceptibility to infection etc.25, 29.

More Details

Positive results from decades of clinical studies show that extracts from Yunzhi mushrooms (which include Polysaccharides K "PSK" and Polysaccharopeptides "PSP") are effective in improving the Quality of Life for patients by alleviating symptoms associated with serious illness treatments.

If you would like to learn more, please refer to the supporting studies page on a variety of reserach conducted on the use of Yunzhi extracts in combating serious illnesses.

Back

Increase survival rates with enhanced immunity

02. Increase in survival rates with enhanced immunity

Numerous clinical studies have been conducted on the effects of Yunzhi extracts on survival rates of various serious illness patients with overwhelmingly positive results. With an optimal level of active ingredients from Yunzhi extracts, Oncozac® can play a powerful role in increasing survival rates of patients7, 17, 21,24, 26.

Oncozac® is also effective in enhancing immune cells such as: T-lymphocytes, B-lymphocytes, monocytes, macrophages, bone marrow cells, natural killer cells and lymphokine-activated cells 2, 3, 13, 23 to strengthen the body’s ability to fight abnormal cells and other infections3,23.

More Details

Whilst survival rates differ based on the serious illness type, the overall trend for Yunzhi-based adjuvant therapies is overwhelmingly positive. For example, it has been scientifically proven that for Breast-related serious illnesses, a specific group of Stage IIA T2N1 and ER negative patients had a 5-year overall survival rate of 95.7% when Yunzhi extracts were combined with chemotherapy, as opposed to 80.8% for a group with chemotherapy alone16.

Furthermore, the body's immune system is critical in maintaining the longevity of ones' health. Oncozac® is scientifically proven to significantly enhance the body’s immunity3,13, therefore reducing the chances of infection3,23 through the increase of antibodies and a variety of cytokines such as: interleukin-2, interleukin-6, interferon and TNF3,23.

Back

Pre-treatment preparation

03.Pre-treatment preparation

Some patients may be advised by medical professionals that they are not able to undergo treatment due to their body's weak immune system or lack of White Blood Cells. Oncozac® is effective in stimulating and proliferating immune cells (such as White Blood Cells, Bone Marrow Cells and Macrophages)2,3,13, therefore enhancing patients' immune systems7,12 and allowing some patients to undergo treatments.

More Details

While serious illness treatments such as chemotherapy, radiotherapy, or surgery are designed to eliminate abnormal cells, these treatments also take a toll on our healthy cells as well, impairing our immune system during the process. Stimulating the growth of immune cells not only ensures patients can resume their treatments, but it also reduces the chance of infection during treatment3, 23.

Back

Post-treatment maintenance

04.Post-treatment maintenance

One of the major complications of treatments is the damage caused to a patients' immune system, which may prevent patients from continuing their treatment. Oncozac® is effective in activating the immune system and restoring immune cells to healthy levels3,13, therefore allowing some patients with weakened immune systems to resume their treatments.

More Details

While serious illness treatments such as chemotherapy, radiotherapy, or surgery are designed to eliminate abnormal cells, these treatments also take a toll on our healthy cells as well, impairing our immune system during the process. Stimulating the growth of immune cells not only ensures patients can resume their treatments, but it also reduces the chance of infection during treatment3, 23.

Back

Reduction in the chance of recurrence

05.Reduction in the chance of recurrence

Oncozac® helps to suppress the spread and growth of abnormal cells7,11,14,15,18,27, helping to reduce the chance of recurrence which may make serious illnesses more manageable for patients.

More Details

Evidence-based research has revealed that Yunzhi extracts have tumoricidal effects in addition to enhancing the immune system. In clinical studies it was found that tumor sizes in animals were reduced1, 15 with the addition of Yunzhi extracts. Furthermore, when assessing liver and breast tumors specifically, the growth of abnormal cells in the liver and breast were suppressed28 as well; the growth of abnormal cells from the stomach, lung, bone marrow, blood-forming tissues, and lymph node were also markedly inhibited20.

Back

Pre-activation of immunity Potential risks of a weak immune system

Immune cells may be too scarce or weak to be effective in protecting the body.
Serious illness treatments eliminate both abnormal cells and immune cells, further weakening our immune system; this results in our immune cells requiring a boost to be effective in attacking vulnerable abnormal cells after treatment** Treatments such as chemotherapy, radiotherapy, immunotherapy etc. are required to weaken abnormal cells before immune cells are able to eliminate them - The immune system itself cannot eliminate abnormal cells on its own

01.Insufficient potency of defence from immune cells

Immune cells may be too scarce or weak to be effective in protecting the body.

02.Collateral damage from treatments

Serious illness treatments eliminate both abnormal cells and immune cells, further weakening our immune system; this results in our immune cells requiring a boost to be effective in attacking vulnerable abnormal cells after treatment** Treatments such as chemotherapy, radiotherapy, immunotherapy etc. are required to weaken abnormal cells before immune cells are able to eliminate them - The immune system itself cannot eliminate abnormal cells on its own

Sorry, your browser does not support inline SVG.
A boost to immunity triggered by ONCO-Z® Restoration of weakened immunological responsiveness Activated immune cells providing a potent attack against abnormal cells
A boost to immunity triggered by ONCO-Z®

01.A boost to immunity triggered by ONCO-Z®

Restoration of weakened immunological responsiveness

02.Restoration of weakened immunological responsiveness

Activated immune cells providing a potent attack against abnormal cells

03.Activated immune cells providing a potent attack against abnormal cells after treatment**After Serious Illness treatments weaken the defense mechanisms of abnormal cells, Oncozac® can stimulate immune cells to attack the vulnerable abnormal cells, thus encouraging the elimination process

Sorry, your browser does not support inline SVG.

Product highlights Contains 100% Yunzhi. With proven results in helping patients stimulate immunity and cope with serious illness

Co-developed with CUHK

Co-developed with CUHK

Co-developed with CUHK

Oncozac® is a new generation Yunzhi-derived adjunct remedy with enhanced efficacy^ developed for those combating serious illnesses. Developed through rigorous pharmaceutical research conducted in the School of Pharmacy, The Chinese University of Hong Kong (CUHK), Oncozac® contains ONCO-Z® which is produced by Purapharm's proprietary production technologies.^Internal research of comparison between different coriolus versicolor products in response to in vitro mitogenic activity

The mitogenic activity level of Yunzhi products on the market
^Internal Research of comparison between different coriolus versicolor products in response to in vitro mitogenic activity

Up to 6x more effective than similar products8

The mitogenic activity level of Yunzhi products on the market

Experiments have revealed that ONCO-Z® is up to 6 times more effective in stimulating the proliferation of immune cells than similar prodcuts on the market. In immunological tests, an optimal dosage of ONCO-Z® for 7 consecutive days is shown to boost immune cells and in turn reduce the risk of infection8.

Certification 1st Chinese medicine ingredient verified by the United States Pharmacopeial Convention (USP)*

  • The ingredients meet label or certificate of analysis claims for identity, strength, purity, and quality
  • The ingredients are consistent in quality from batch to batch
  • The ingredients are prepared in accordance with accepted manufacturing practices
  • In addition to USP-verification, Oncozac® also complies with GMP and SGS standards
    *Oncozac®'s only ingredient ONCO-Z® is the dietary ingredient verified by the United States Pharmacopeial Convention
Learn more
Research & innovation backgound Research & innovation Research & innovation Background pattern

Research & innovation Continuous research and experimentation

For over two decades, we have been collaborating with leading research institutions to conduct extensive tests on the efficacy of Yunzhi in treating serious illnesses.

Collaborations with leading research institutions worldwide

Oncozac® has been researched and developed with the Chinese University of Hong Kong since 1997.

Purapharm® has also worked with various public and private research institutions to support Oncozac®'s efficacy and safety.

Continued R&D investments for further clinical research

We continue to invest in Research & Development while working with leading research institutions both in Hong Kong and abroad. As a next step, we are working towards clinical studies for Triple-Negative Breast-related serious illness patients.

Learn more

Manufacturing Meeting the highest standards

Following Good Manufacturing Practice (GMP), every step in the production process is strictly monitored to ensure the safety and reliability of Oncozac®.

Learn more
Yunzhi harvesting Oncozac® is produced from natural Yunzhi grown in PuraPharm® managed forests.
Wild Yunzhi harvesting
Patented freeze-drying technology11 Our proprietary extraction process used to produce Oncozac®, which contains the active ingredient ONCO-Z®.11
Patented freeze-drying technology
Stringent manufacturing process Complying with the highest internationally-recognized standards including USP, TGA & GMP.
Stringent manufacturing process
Quality control and packaging All final products pass extensive tests to ensure safety and the highest quality standards.
Quality control and packaging

Administration Who is Oncozac® for?

Oncozac® is suitable for patients with serious illnesses, patients receiving serious illness treatment, and survivors of serious illness.

Recommended dosage
Recommended dosage Recommended dosage Recommended dosage

Resources Science driven by humanity

Bringing longer, healthier, happier lives through the innovation and modernization of herbal medicines and herbal products.

About Purapharm® Your trusted adjuvant therapy and healthcare product provider.

Purapharm®, the parent company of Nong's, is the market leader for Concentrated Chinese Medicine Granules (CCMG) products in Hong Kong, holding an impressive 83.4%* of the market share in CCMG.*Based on Euromonitor International’s research conducted in May 2021 on Concentrated Chinese Medicine Granules (CCMG) market (in terms of prescription revenue in 2020) in Hong Kong.

Learn more
Loading...